291 related articles for article (PubMed ID: 3017362)
41. Forskolin inhibits the Gs-stimulated adenylate cyclase in rat ascites hepatoma AH66F cells.
Miyamoto K; Sanae F; Koshiura R; Matsunaga T; Hasegawa T; Takagi K; Satake T
Exp Cell Res; 1989 Sep; 184(1):219-27. PubMed ID: 2551705
[TBL] [Abstract][Full Text] [Related]
42. Adenylate cyclase of platelets from spontaneously hypertensive rats: reduction of the inhibition by GTP.
Coquil JF; Brunelle G
Biochem Biophys Res Commun; 1989 Aug; 162(3):1265-71. PubMed ID: 2504157
[TBL] [Abstract][Full Text] [Related]
43. Comparison of the epinephrine-mediated activation of adenylate cyclase in plasma membranes from liver and ascites hepatomas of rats.
Okamura N; Terayama H
Biochim Biophys Acta; 1976 Dec; 455(2):297-314. PubMed ID: 187240
[TBL] [Abstract][Full Text] [Related]
44. Forms of adenylate cyclase, activation and/or potentiation by forskolin.
Shi QH; Ruiz JA; Ho RJ
Arch Biochem Biophys; 1986 Nov; 251(1):156-65. PubMed ID: 3789730
[TBL] [Abstract][Full Text] [Related]
45. Effects of dimethyl sulfoxide and other dipolar aprotic solvents on rat hepatic adenylate cyclase. Potentiating effects on glucagon and guanylylimidodiphosphate stimulation.
Hynie S; Klenerová V
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jan; 310(3):231-6. PubMed ID: 7374794
[TBL] [Abstract][Full Text] [Related]
46. Modulation by n-alkanols of rat cardiac adenylate cyclase activity.
Chatelain P; Robberecht P; Waelbroeck M; Camus JC; Christophe J
J Membr Biol; 1986; 93(1):23-32. PubMed ID: 3795260
[TBL] [Abstract][Full Text] [Related]
47. Changes in the form of Arrhenius plots of the activity of glucagon-stimulated adenylate cyclase and other hamster liver plasma-membrane enzymes occurring on hibernation.
Houslay MD; Palmer RW
Biochem J; 1978 Sep; 174(3):909-19. PubMed ID: 728095
[TBL] [Abstract][Full Text] [Related]
48. Forskolin-insensitive adenylate cyclase in cultured cells of Choristoneura fumiferana (Insecta).
Gole JW; Orr GL; Downer RG
Biochem Biophys Res Commun; 1987 Jun; 145(3):1192-7. PubMed ID: 2440427
[TBL] [Abstract][Full Text] [Related]
49. Receptor binding and adenylate cyclase activities of glucagon analogues modified in the N-terminal region.
McKee RL; Pelton JT; Trivedi D; Johnson DG; Coy DH; Sueiras-Diaz J; Hruby VJ
Biochemistry; 1986 Apr; 25(7):1650-6. PubMed ID: 3011069
[TBL] [Abstract][Full Text] [Related]
50. The role of a guanine nucleotide-binding protein in the activation of rat liver plasma-membrane adenylate cyclase by forskolin.
Wong SK; Martin BR
Biochem J; 1983 Dec; 216(3):753-9. PubMed ID: 6320798
[TBL] [Abstract][Full Text] [Related]
51. Adenylate cyclase activity in hepatic plasma membranes from obese-hyperglycaemic mice [proceedings].
Dehaye JP; Winand J; Christophe J
Biochem Soc Trans; 1977; 5(4):1162-4. PubMed ID: 913814
[No Abstract] [Full Text] [Related]
52. Effect of dietary fat and cholesterol supplements on glucagon receptor binding and adenylate cyclase activity of rat liver plasma membrane.
Lee CR; Hamm MW
J Nutr; 1989 Apr; 119(4):539-46. PubMed ID: 2539445
[TBL] [Abstract][Full Text] [Related]
53. Stimulatory and inhibitory regulation of myocardial adenylate cyclase by 5'-guanylyl-imidodiphosphate.
Steinberg SF; Chow YK; Bilezikian JP
Biochem Pharmacol; 1987 Mar; 36(5):757-64. PubMed ID: 3103629
[TBL] [Abstract][Full Text] [Related]
54. Forskolin-induced change of the size of adenylate cyclase.
Bouhelal R; Guillon G; Homburger V; Bockaert J
J Biol Chem; 1985 Sep; 260(20):10901-4. PubMed ID: 4040911
[TBL] [Abstract][Full Text] [Related]
55. Solubilization and separation of the glucagon receptor and adenylate cyclase in guanine nucleotide-sensitive states.
Welton AF; Lad PM; Newby AC; Yamamura H; Nicosia S; Rodbell M
J Biol Chem; 1977 Sep; 252(17):5947-50. PubMed ID: 197078
[TBL] [Abstract][Full Text] [Related]
56. Thermodependence of basal and stimulated cardiac adenylate cyclase activity in normotensive and spontaneously hypertensive rats.
Chatelain P; Robberecht P; De Neef P; Camus JC; Christophe J
J Mol Cell Cardiol; 1983 Dec; 15(12):811-9. PubMed ID: 6663629
[TBL] [Abstract][Full Text] [Related]
57. Kappa-opiate agonists inhibit adenylate cyclase and produce heterologous desensitization in rat spinal cord.
Attali B; Saya D; Vogel Z
J Neurochem; 1989 Feb; 52(2):360-9. PubMed ID: 2536070
[TBL] [Abstract][Full Text] [Related]
58. GDP does not mediate but rather inhibits hormonal signal to adenylate cyclase.
Kimura N; Shimada N
J Biol Chem; 1983 Feb; 258(4):2278-83. PubMed ID: 6296138
[TBL] [Abstract][Full Text] [Related]
59. Decreased stimulation of adenylate cyclase by growth hormone-releasing factor in the anterior pituitary of old rats.
Robberecht P; Gillard M; Waelbroeck M; Camus JC; De Neef P; Christophe J
Neuroendocrinology; 1986; 44(4):429-32. PubMed ID: 3102990
[TBL] [Abstract][Full Text] [Related]
60. Activation of adenylate cyclase in bovine corpus-luteum membranes by human choriogonadotropin, guanine nucleotides and NaF.
Lydon NB; Young JL; Stansfield DA
Biochem J; 1981 Sep; 198(3):631-8. PubMed ID: 7326028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
